NCT06767046 KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06108531 Tumor Exosome Liquid Biopsy Strategy to Diagnose Pancreatic Cancer Status ENROLLING_BY_INVITATION Phase N/A
NCT01078662 Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats Status COMPLETED Phase PHASE2